Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,471
Total Claims
$651K
Drug Cost
1,093
Beneficiaries
$596
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-69%
Opioid rate vs peers
0.7% vs 2.2% avg
-58%
Cost per patient vs peers
$596 vs $1,411 avg
-9%
Brand preference vs peers
9.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
73
Opioid Claims
$419
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,001 claims · $495K
Generic: 9,363 claims · $149K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 83 | $115K |
| Empagliflozin | 24 | $41K |
| Sitagliptin Phosphate | 23 | $36K |
| Fluticasone/Umeclidin/Vilanter | 28 | $32K |
| Insulin Detemir | 30 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 43 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $15K |
| Insulin Aspart Prot/Insuln Asp | 12 | $13K |
| Umeclidinium Brm/Vilanterol Tr | 19 | $12K |
| Insulin Aspart | 20 | $11K |
| Atorvastatin Calcium | 901 | $11K |
| Insulin Nph Hum/Reg Insulin Hm | 15 | $10K |
| Fluticasone/Vilanterol | 18 | $9,393 |
| Linaclotide | 11 | $8,297 |
| Albuterol Sulfate | 187 | $8,030 |
Prescribing Profile
Patient Profile
73
Avg Age
53%
Female
1.80
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data